A detailed history of Rhumbline Advisers transactions in Rx Sight, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 46,810 shares of RXST stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,810
Previous 47,465 1.38%
Holding current value
$2.16 Million
Previous $2.86 Million 18.98%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$40.78 - $57.04 $26,710 - $37,361
-655 Reduced 1.38%
46,810 $2.31 Million
Q2 2024

Aug 01, 2024

BUY
$50.42 - $64.29 $435,225 - $554,951
8,632 Added 22.23%
47,465 $2.86 Million
Q1 2024

May 09, 2024

BUY
$35.51 - $57.92 $45,275 - $73,848
1,275 Added 3.39%
38,833 $2 Million
Q4 2023

Feb 08, 2024

BUY
$20.91 - $40.9 $36,132 - $70,675
1,728 Added 4.82%
37,558 $1.51 Million
Q3 2023

Nov 09, 2023

BUY
$27.05 - $33.37 $31,053 - $38,308
1,148 Added 3.31%
35,830 $999,000
Q2 2023

Aug 08, 2023

BUY
$16.37 - $28.9 $64,939 - $114,646
3,967 Added 12.92%
34,682 $998,000
Q1 2023

May 11, 2023

BUY
$12.58 - $16.68 $60,321 - $79,980
4,795 Added 18.5%
30,715 $512,000
Q4 2022

Feb 14, 2023

BUY
$9.93 - $14.2 $5,630 - $8,051
567 Added 2.24%
25,920 $328,000
Q3 2022

Nov 10, 2022

BUY
$11.19 - $15.85 $18,888 - $26,754
1,688 Added 7.13%
25,353 $304,000
Q2 2022

Aug 11, 2022

BUY
$10.61 - $16.66 $120,020 - $188,457
11,312 Added 91.57%
23,665 $333,000
Q1 2022

May 12, 2022

BUY
$8.97 - $14.03 $110,806 - $173,312
12,353 New
12,353 $153,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.27B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.